- Home
- USA vs HUMAW Comparison
USA vs HUMAW Comparison
Compare USA & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USA
- HUMAW
- Stock Information
- Founded
- USA 1986
- HUMAW 2004
- Country
- USA United States
- HUMAW United States
- Employees
- USA N/A
- HUMAW 220
- Industry
- USA Finance Companies
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- USA Finance
- HUMAW Health Care
- Exchange
- USA Nasdaq
- HUMAW Nasdaq
- Market Cap
- USA N/A
- HUMAW N/A
- IPO Year
- USA N/A
- HUMAW N/A
- Fundamental
- Price
- USA $6.95
- HUMAW $0.45
- Analyst Decision
- USA
- HUMAW
- Analyst Count
- USA 0
- HUMAW 0
- Target Price
- USA N/A
- HUMAW N/A
- AVG Volume (30 Days)
- USA 880.5K
- HUMAW 14.2K
- Earning Date
- USA 01-01-0001
- HUMAW 03-21-2025
- Dividend Yield
- USA 9.66%
- HUMAW N/A
- EPS Growth
- USA N/A
- HUMAW N/A
- EPS
- USA N/A
- HUMAW N/A
- Revenue
- USA N/A
- HUMAW N/A
- Revenue This Year
- USA N/A
- HUMAW N/A
- Revenue Next Year
- USA N/A
- HUMAW N/A
- P/E Ratio
- USA N/A
- HUMAW N/A
- Revenue Growth
- USA N/A
- HUMAW N/A
- 52 Week Low
- USA $5.62
- HUMAW $1.18
- 52 Week High
- USA $7.09
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- USA 70.13
- HUMAW N/A
- Support Level
- USA $6.64
- HUMAW N/A
- Resistance Level
- USA $6.74
- HUMAW N/A
- Average True Range (ATR)
- USA 0.07
- HUMAW 0.00
- MACD
- USA 0.02
- HUMAW 0.00
- Stochastic Oscillator
- USA 98.86
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.